|  | Cancer | Skin Cancer

Photolyase: How Light-Powered DNA Repair Prevents Skin Cancer

Photolyase is a flavoprotein enzyme that uses visible/blue light (300–500 nm) to directly reverse UV-induced DNA damage—specifically cyclobutane pyrimidine dimers (CPDs) and (6-4) photoproducts.

Mechanism: Photoreactivation (4 Steps)

  1. Light absorption: Antenna chromophore (MTHF or 8-HDF) captures photon → energy transfer to catalytic FADH⁻ cofactor.
  2. Damage recognition: Photolyase scans DNA, binds specifically to CPD or 6-4PP lesions.
  3. Photochemical cleavage: Excited FADH⁻ transfers electron to dimer → splits covalent bonds → restores original bases.
  4. Release & recycle: Enzyme dissociates, ready for next lesion.

Biological Significance

  • Ubiquitous in bacteria, plants, fungi, marsupials, some fish/amphibians.
  • Absent in placental mammals (including humans)—we rely on nucleotide excision repair (NER), a slower, light-independent pathway.
  • Evolutionary loss correlates with nocturnal ancestry and placental development.

Therapeutic Potential

  • Topical photolyase (liposomal) in sunscreens/after-sun products (e.g., ISDIN Eryfotona, Neova DNA Repair) — human trials show ↓ CPDs, ↓ actinic keratoses, ↓ new skin cancers in XP patients.
  • Gene therapy / mRNA delivery explored for xeroderma pigmentosum.

Limitations

  • Requires light exposure (not deep tissue).
  • Does not repair oxidative damage (8-oxoG), strand breaks, or crosslinks.
  • Not a substitute for UV avoidance, sunscreen, clothing, and NER capacity.

Photolyase is nature's "undo button" for UV mutations—humans lost it, but biotechnology is bringing it back.

Skin Cancer - Related Articles